Yazar "Gurer, B." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Effects of reinforcing materials on durability of bone cement: In vitro experimental study
    (BioMed Central Ltd., 2018) Karakus, O.; Karaman, O.; Gurer, B.; Saygi, B.
    Background: Bone cement is one of the most commonly used products in orthopedic surgery. Among common indications for its use are total joint replacement, bone and joint reconstructions, fracture fixation, treatment of bone infections, and treatment of osteoporotic vertebral fractures. Endurance is still questionable. The aim of our study is to find out the effect of structure strengtheners on compression pressure measurements of bone cement. Methods: There were four groups in this study: group 1, 40 cm3 pure bone cement (PMMA); group 2, 40 cm3 bone cement with %25 titanium dust; group 3, 40 cm3 bone cement with %25 steel dust; and group 4, 40 cm3 bone cement with %25 silica fume mixtures were prepared. These mixtures were frozen in 6-mm-width, 12-mm-height molds in cylindrical shape. Axial compression was made to these molds. Results: Compression pressure measurements of the pure cement group ranged between 79.2 and 81.1 MPa; average was 80.25 ± 0.42 MPa. Measurements of titanium-added group ranged from 79.5 to 81.2 MPa; average was 80.46 ± 0.68 MPa. Steel-added group ranged from 79 to 82.2 MPa; average was 80.73 ± 0.57 MPa. For silica fume, measurements ranged from 89.1 to 91.4 MPa and average was 90.41 ± 0.57 MPa. The highest compression pressure values were gathered from the silica fume (p = 0.001). Conclusion: The construction reinforcer silica fume could be mixed with PMMA homogeneously and was superior to the other biocompatible materials that we had used in compression pressure tests. Beyond dispute, silica fume is a reinforcer which also increases the strength of the bone cement. © 2018 The Author(s).
  • Küçük Resim Yok
    Öğe
    In vivo cartilage tissue engineering
    (BioMed Central Ltd., 2018) Gurer, B.; Cabuk, S.; Karakus, O.; Yilmaz, N.; Yilmaz, C.
    Background: Biologic treatment options for cartilage injuries require chondrocyte expansion using cell culture. Clinical application is accomplished in two surgical sessions and is expensive. If isolation of chondrocytes and stimulus for proliferation and extracellular matrix synthesis can be achieved in vivo, the treatment can be performed in one session and the cost can be reduced. Methods: A 2.5-cm diameter full-thickness chondral defect was created in the knees of five groups of sheep. In one group, some of the chondral tissues obtained from the creation of the defect were diced into small pieces and were placed into the defect and were covered with a collagen membrane (MIV group). In the other group, the collagen membrane was soaked in collagenase prior to usage. In the next group, the collagen membrane was soaked in both collagenase and growth factors. Matrix-induced autologous chondrocyte implantation (MACI) was applied to another group in two sessions, and the last group was left untreated. After 15 weeks of follow-up, repair tissues were compared macroscopically, histomorphometrically, and biochemically for tissue concentrations of glycosaminoglycan and type II collagen. Results: MACI and MIV groups demonstrated better healing than others and were similar. Addition of collagenase or growth factors did not improve the results. Addition of collagenase did not have detrimental effect on the surrounding cartilage. Conclusions: With the described method, it is possible to obtain comparable results with MACI. Further studies are also needed to see if it works similarly in humans. © 2018 The Author(s).